A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis
Chemotherapy typically destroys the tumor mass but rarely eradicates the cancer stem cells (CSCs) that can drive metastatic recurrence. A key current challenge is finding ways to eradicate CSCs and suppress their characteristics. Here, we report a prodrug, Nic-A, created by combining a carbonic anhy...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | anglais |
| Publié: |
2023
|
| Accès en ligne: | https://doi.org/10.1073/pnas.2304081120 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|